The global Extended Release Drug market is growing with significant growth from last couple of years and in the year 2020, the market of Extended Release Drug was valued at USD XX Million and is expected to reach USD XXX million by the end of the year 2027. ,
The report is designed to offer very important and crucial information about the Extended Release Drug market and industry. For the purpose of this study, the market of Extended Release Drug has been segmented into type, application, regions and countries. Each segment of the report will provide a detailed analysis of the market and in terms of quantitative information, the report will offer market revenue (USD Million), market share in %, market CAGR from 2021 to 2027.
The report also provides a detailed qualitative analysis of the Extended Release Drug market which includes Market Drivers to explain the driving factors of the market and demand, Market Challenges to explain the restraints of the market and growth and Market Opportunities to explain the upcoming trends and opportunities left for the newcomers of the market and where can the existing companies focus in order to gain competitive advantage. The Extended Release Drug report also provides a detailed Porter's Five Forces, Micro and Macro Economic analysis which can help the readers and the users of the report to understand and draw a sound business decision.
The readers of the report will have a deep , insightful analysis that will help in understanding the market size, market share, CAGR, country specific analysis and market share for Extended Release Drug market.
Market Segmentation
One of the very important chapter of Extended Release Drug market report is competitive analysis. In this chapter, we have presented a detailed overview of the competition and have provided the market revenue of each company along with the market share.
The companies mentioned in the report are:
Pfizer
Mallinckrodt
Teva
Johnson & Johnson
Endo Pharmaceuticals
Purdue Pharma
Mylan
Hisamitsu Pharmaceutical
Sun Pharmaceutical Industries
Note: We can also add companies which are not part of the above list
Global Extended Release Drug Market Analysis By Type
Sustained Release Drug
Controlled Release Drug
In the year 2020, Sustained Release Drug segment had XX% of market share and in terms of value, the Sustained Release Drug market was valued at USD XX Million. , It is expected that Sustained Release Drug will have XX% of market share by the end of year 2027 and the incremental growth from 2021 till 2027 is expected to be USD XX Million.
Global Extended Release Drug Market Analysis By Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Hospital Pharmacy segment is expected to account for XX% of market share by the end of year 2027 from XX% in 2020. The Hospital Pharmacy is expected to grow at USD XX million by the end of year 2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The following regions has been further bifurcated into countries to provide an insightful analysis for the readers.
Global Extended Release Drug market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
Report Includes:
- 112 Pages and Over 125 Tables and Figures
- An overview of the global Extended Release Drug market ,
- Estimation of the market size and analyses of global market trends, with data from 2019, 2020, and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the new technological developments and discussion on for Extended Release Drug Market
- Identification of market drivers, restraints and other forces impacting the global market and description of regulatory and environmental developments
- Comprehensive profiles of major organizations and contractors
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Extended Release Drug Market Size Growth Rate by Type (2016-2027)
1.4.2 Sustained Release Drug
1.4.3 Controlled Release Drug
1.5 Market by Application
1.5.1 Global Extended Release Drug Market Share by Application (2021-2027)
1.5.2 Hospital Pharmacy
1.5.3 Retail Pharmacy
1.5.4 Online Pharmacy
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Extended Release Drug Market Size
2.2 Extended Release Drug Growth Trends by Regions
2.2.1 Extended Release Drug Market Size by Regions (2021-2027)
2.2.2 Extended Release Drug Market Share by Regions (2016-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter s Five Forces Analysis
3 Market Share by Key Players
3.1 Extended Release Drug Market Size by by Players
3.1.1 Global Extended Release Drug Revenue by by Players (2016-2020)
3.1.2 Global Extended Release Drug Revenue Market Share by by Players (2016-2020)
3.1.3 Global Extended Release Drug Market Concentration Ratio (CR5 and HHI)
3.2 Extended Release Drug Key Players Head office and Area Served
3.3 Key Players Extended Release Drug Product/Solution/Service
3.4 Date of Enter into Extended Release Drug Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Extended Release Drug Market Size by Type (2016-2020)
4.2 Global Extended Release Drug Market Size by Application (2016-2020)
5 North America
5.1 North America Extended Release Drug Market Size (2016-2020)
5.2 Extended Release Drug Key Players in North America
5.3 North America Extended Release Drug Market Size by Type
5.4 North America Extended Release Drug Market Size by Application
6 Europe
6.1 Europe Extended Release Drug Market Size (2016-2020)
6.2 Extended Release Drug Key Players in Europe
6.3 Europe Extended Release Drug Market Size by Type
6.4 Europe Extended Release Drug Market Size by Application
7 Asia-Pacific
7.1 Asia-Pacific Extended Release Drug Market Size (2016-2020)
7.2 Extended Release Drug Key Players in Asia-Pacific
7.3 Asia-Pacific Extended Release Drug Market Size by Type
7.4 Asia-Pacific Extended Release Drug Market Size by Application
8 International Players Profiles
8.1 Pfizer
8.1.1 Pfizer Company Details
8.1.2 Company Description and Business Overview
8.1.3 Extended Release Drug Introduction
8.1.4 Pfizer Revenue in Extended Release Drug Business (2016-2020))
8.1.5 Pfizer Recent Development
8.2 Mallinckrodt
8.2.1 Mallinckrodt Company Details
8.2.2 Company Description and Business Overview
8.2.3 Extended Release Drug Introduction
8.2.4 Mallinckrodt Revenue in Extended Release Drug Business (2016-2020)
8.2.5 Mallinckrodt Recent Development
8.3 Teva
8.3.1 Teva Company Details
8.3.2 Company Description and Business Overview
8.3.3 Extended Release Drug Introduction
8.3.4 Teva Revenue in Extended Release Drug Business (2016-2020)
8.3.5 Teva Recent Development
8.4 Johnson & Johnson
8.4.1 Johnson & Johnson Company Details
8.4.2 Company Description and Business Overview
8.4.3 Extended Release Drug Introduction
8.4.4 Johnson & Johnson Revenue in Extended Release Drug Business (2016-2020)
8.4.5 Johnson & Johnson Recent Development
8.5 Endo Pharmaceuticals
8.5.1 Endo Pharmaceuticals Company Details
8.5.2 Company Description and Business Overview
8.5.3 Extended Release Drug Introduction
8.5.4 Endo Pharmaceuticals Revenue in Extended Release Drug Business (2016-2020)
8.5.5 Endo Pharmaceuticals Recent Development
8.6 Purdue Pharma
8.6.1 Purdue Pharma Company Details
8.6.2 Company Description and Business Overview
8.6.3 Extended Release Drug Introduction
8.6.4 Purdue Pharma Revenue in Extended Release Drug Business (2016-2020)
8.6.5 Purdue Pharma Recent Development
8.7 Mylan
8.7.1 Mylan Company Details
8.7.2 Company Description and Business Overview
8.7.3 Extended Release Drug Introduction
8.7.4 Mylan Revenue in Extended Release Drug Business (2016-2020)
8.7.5 Mylan Recent Development
8.8 Hisamitsu Pharmaceutical
8.8.1 Hisamitsu Pharmaceutical Company Details
8.8.2 Company Description and Business Overview
8.8.3 Extended Release Drug Introduction
8.8.4 Hisamitsu Pharmaceutical Revenue in Extended Release Drug Business (2016-2020)
8.8.5 Hisamitsu Pharmaceutical Recent Development
8.9 Sun Pharmaceutical Industries
8.9.1 Sun Pharmaceutical Industries Company Details
8.9.2 Company Description and Business Overview
8.9.3 Extended Release Drug Introduction
8.9.4 Sun Pharmaceutical Industries Revenue in Extended Release Drug Business (2016-2020)
8.9.5 Sun Pharmaceutical Industries Recent Development
9 Market Forecast 2021-2027
9.1 Market Size Forecast by Product (2021-2027)
9.2 Market Size Forecast by Application (2021-2027)
9.3 Market Size Forecast by Regions
9.4 North America
9.5 Europe
9.6 Asia-Pacific
10 Analyst's Viewpoints/Conclusions
11 Appendix
11.1 Research Methodology
11.1.1 Methodology/Research Approach
11.1.1.1 Research Programs/Design
11.1.1.2 Market Size Estimation
11.1.1.3 Market Breakdown and Data Triangulation
11.1.2 Data Source
11.1.2.1 Secondary Sources
11.1.2.2 Primary Sources
11.2 Disclaimer
List of Tables and Figures
List of Tables and Figures
Table Extended Release Drug Key Market Segments
Table Key Players Extended Release Drug Covered
Table Global Extended Release Drug Market Size Growth Rate by Type 2020-2027 (Million US$)
Figuer Sustained Release Drug Figures
Table Key Players of Sustained Release Drug
Figuer Controlled Release Drug Figures
Table Key Players of Controlled Release Drug
Table Global Extended Release Drug Market Size Growth by Application 2021-2027 (Million US$)
Figure Global Extended Release Drug Market Share by Application in 2020 & 2027
Figure Hospital Pharmacy Case Studies
Figure Retail Pharmacy Case Studies
Figure Online Pharmacy Case Studies
Figure Extended Release Drug Report Years Considered
Figure Global Extended Release Drug Market Size and Growth Rate 2016-2027 (Million US$)
Table Global Extended Release Drug Market Size by Regions 2021-2027 (Million US$)
Table Global Extended Release Drug Market Size by Regions 2021-2027 (Million US$)
Table Global Extended Release Drug Market Share by Regions 2016-2020
Figure Global Extended Release Drug Market Share by Regions 2016-2020
Figure Global Extended Release Drug Market Share by Regions in 2020
Table Market Top Trends
Table Key Drivers: Impact Analysis (2021-2027)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Extended Release Drug Revenue by by Players (2016-2020) (Million US$)
Table Global Extended Release Drug Market Share by by Players (2016-2020)
Figure Global Extended Release Drug Market Share by by Players in 2020
Table Global Extended Release Drug by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Extended Release Drug Product/Solution/Service
Table Date of Enter into Extended Release Drug Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Extended Release Drug Market Size by Type (2016-2020) (Million US$)
Table Global Extended Release Drug Market Size Share by Type (2016-2020)
Figure Global Extended Release Drug Market Size Market Share by Type (2016-2020)
Table Global Extended Release Drug Market Size by Application (2016-2020) (Million US$)
Table Global Extended Release Drug Market Size Share by Application (2016-2020)
Figure Global Extended Release Drug Market Size Market Share by Application (2016-2020)
Figure Global Extended Release Drug Revenue Market Share by Application in 2020
Figure North America Extended Release Drug Market Size 2016-2020 (Million US$)
Table North America Key Players Extended Release Drug Revenue (2019-2020) (Million US$)
Table North America Key Players Extended Release Drug Market Share (2019-2020)
Table North America Extended Release Drug Market Size by Type 2016-2020 (Million US$)
Table North America Extended Release Drug Market Share by Type 2016-2020
Table North America Extended Release Drug Market Size by Application 2016-2020 (Million US$)
Table North America Extended Release Drug Market Share by Application 2016-2020
Figure Europe Extended Release Drug Market Size 2016-2020 (Million US$)
Table Europe Key Players Extended Release Drug Revenue (2019-2020) (Million US$)
Table Europe Key Players Extended Release Drug Market Share (2019-2020)
Table Europe Extended Release Drug Market Size by Type 2016-2020 (Million US$)
Table Europe Extended Release Drug Market Share by Type 2016-2020
Table Europe Extended Release Drug Market Size by Application 2016-2020 (Million US$)
Table Europe Extended Release Drug Market Share by Application 2016-2020
Figure Asia-Pacific Extended Release Drug Market Size 2016-2020 (Million US$)
Table Asia-Pacific Key Players Extended Release Drug Revenue (2019-2020) (Million US$)
Table Asia-Pacific Key Players Extended Release Drug Market Share (2019-2020)
Table Asia-Pacific Extended Release Drug Market Size by Type 2016-2020 (Million US$)
Table Asia-Pacific Extended Release Drug Market Share by Type 2016-2020
Table Asia-Pacific Extended Release Drug Market Size by Application 2016-2020 (Million US$)
Table Asia-Pacific Extended Release Drug Market Share by Application 2016-2020
Table Pfizer Company Details
Table Pfizer Revenue in Extended Release Drug Business 2016-2020 (Million US$)
Figure Pfizer Revenue Growth Rate in Extended Release Drug Business (2016-2020)
Table Pfizer Recent Development
Table Mallinckrodt Company Details
Table Mallinckrodt Revenue in Extended Release Drug Business 2016-2020 (Million US$)
Figure Mallinckrodt Revenue Growth Rate in Extended Release Drug Business (2016-2020)
Table Mallinckrodt Recent Development
Table Teva Company Details
Table Teva Revenue in Extended Release Drug Business 2016-2020 (Million US$)
Figure Teva Revenue Growth Rate in Extended Release Drug Business (2016-2020)
Table Teva Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Extended Release Drug Business 2016-2020 (Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Extended Release Drug Business (2016-2020)
Table Johnson & Johnson Recent Development
Table Endo Pharmaceuticals Company Details
Table Endo Pharmaceuticals Revenue in Extended Release Drug Business 2016-2020 (Million US$)
Figure Endo Pharmaceuticals Revenue Growth Rate in Extended Release Drug Business (2016-2020)
Table Endo Pharmaceuticals Recent Development
Table Purdue Pharma Company Details
Table Purdue Pharma Revenue in Extended Release Drug Business 2016-2020 (Million US$)
Figure Purdue Pharma Revenue Growth Rate in Extended Release Drug Business (2016-2020)
Table Purdue Pharma Recent Development
Table Mylan Company Details
Table Mylan Revenue in Extended Release Drug Business 2016-2020 (Million US$)
Figure Mylan Revenue Growth Rate in Extended Release Drug Business (2016-2020)
Table Mylan Recent Development
Table Hisamitsu Pharmaceutical Company Details
Table Hisamitsu Pharmaceutical Revenue in Extended Release Drug Business 2016-2020 (Million US$)
Figure Hisamitsu Pharmaceutical Revenue Growth Rate in Extended Release Drug Business (2016-2020)
Table Hisamitsu Pharmaceutical Recent Development
Table Sun Pharmaceutical Industries Company Details
Table Sun Pharmaceutical Industries Revenue in Extended Release Drug Business 2016-2020 (Million US$)
Figure Sun Pharmaceutical Industries Revenue Growth Rate in Extended Release Drug Business (2016-2020)
Table Sun Pharmaceutical Industries Recent Development
Table Global Extended Release Drug Market Size by Regions (Million US$) 2021-2027
Figure Global Extended Release Drug Market Size Share by Regions (2021-2027)
Figure Global Extended Release Drug Market Size Share by Regions in 2027
Figure North America Extended Release Drug Market Size Forecast (2021-2027)(Million USD)
Figure Europe Extended Release Drug Market Size Forecast (2021-2027)(Million USD)
Figure Asia-Pacific Extended Release Drug Market Size Forecast (2021-2027)(Million USD)
Table Global Extended Release Drug Market Size by Product (2021-2027) (Million US$)
Figure Global Extended Release Drug Market Size by Product (2021-2027)
Figure Global Extended Release Drug Market Size by Product in 2027
Table Global Extended Release Drug Market Size by Application (2021-2027) (Million US$)
Figure Global Extended Release Drug Market Size by Application (2021-2027)
Figure Global Extended Release Drug Market Size by Application in 2027
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources